United States: Monthly Stock Market Performance Insight - January 2024

Monthly Gainers
1,910
Monthly Losers
3,403
Average Return
-0.65%
Total Stocks
5,508
View Detailed Market Cap Breakdown
Market Cap Monthly Gainers Monthly Losers Average Return Total Stocks
Mega Cap 36 11 3.27% 47
Large Cap 302 395 -1.22% 701
Mid Cap 293 657 -2.68% 953
Small Cap 151 338 -3.48% 492

Monthly Streak Leaders for January 2024

Stock Streak Streak Return
6 months โ†‘ 21.50%

AT&T maintains strong momentum with a 6-month winning streak (14.56 โ†’ 17.69), delivering 21.5% gains. The financials tell a compelling story: 30.6B revenue generating 4.7B net profit (15.3% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

5 months โ†‘ 30.32%

Meta Platforms shows promise with a 5-month winning streak (299.37 โ†’ 390.14), delivering 30.3% gains. The financials tell a compelling story: 48.4B revenue generating 20.8B net profit (43.1% margin) demonstrates exceptional profit margins as of Qtr ending Dec 2024.

2 months โ†“ -19.27%

Palantir consolidates with a 2-month decline (19.93 โ†’ 16.09), down 19.3%. Weak margins on 883.9M revenue with only 217.7M profit (24.6% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

2 months โ†“ -7.03%

UnitedHealth consolidates with a 2-month decline (550.42 โ†’ 511.74), down 7.0%. Weak margins on 109.6B revenue with only 6.5B profit (5.9% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

8 months โ†‘ 19.24%

CNA Financial maintains strong momentum with a 8-month winning streak (36.96 โ†’ 44.07), delivering 19.2% gains. With 3.6B revenue generating only 274.0M profit (7.7% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

7 months โ†‘ 98.74%

CrowdStrike Holdings builds on success with a 7-month winning streak (147.18 โ†’ 292.50), delivering 98.7% gains. Despite 1.1B in revenue and - 111.0M loss (-10.1% margin) as of Qtr ending Apr 2025, the market sees potential beyond current profitability. This momentum suggests confidence in future execution.

10 months โ†“ -33.45%

Pfizer struggles to find footing after a 10-month decline (40.69 โ†’ 27.08), down 33.4%. However, fundamentals remain robust: 13.7B revenue generating 3.0B profit (21.7% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note.

6 months โ†“ -13.49%

Eog Resources navigates difficult waters with a 6-month decline (131.54 โ†’ 113.79), down 13.5%. However, fundamentals remain robust: 5.8B revenue generating 1.5B profit (25.0% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note.

10 months โ†‘ 21.77%

SOC has shown exceptional momentum with 10 consecutive positive months, delivering 21.77% returns.

9 months โ†‘ 332.15%

Abercrombie & Fitch builds on success with a 9-month winning streak (23.58 โ†’ 101.90), delivering 332.1% gains. With 1.1B revenue generating only 81.7M profit (7.4% margin) in Qtr ending Apr 2025, the market prices in future margin expansion potential.

6 months โ†“ -27.09%

Legend Biotech navigates difficult waters with a 6-month decline (75.52 โ†’ 55.06), down 27.1%. Financial struggles compound the decline: despite 195.1M revenue, - 100.9M losses persist (-51.7% margin) as of Qtr ending Mar 2025. Until profitability improves, caution remains warranted.

6 months โ†“ -19.68%

JBT Marel navigates difficult waters with a 6-month decline (122.96 โ†’ 98.76), down 19.7%. Financial struggles compound the decline: despite 854.1M revenue, - 173.0M losses persist (-20.3% margin) as of Qtr ending Mar 2025. Until profitability improves, caution remains warranted.

9 months โ†‘ 32.03%

FSCO has shown exceptional momentum with 9 consecutive positive months, delivering 32.03% returns.

8 months โ†‘ 118.91%

Universal Technical shows consistent strength with a 8-month winning streak (6.45 โ†’ 14.12), delivering 118.9% gains. With 207.4M revenue generating only 11.4M profit (5.5% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

7 months โ†“ -56.80%

Cricut sees continued selling pressure through a 7-month decline (12.13 โ†’ 5.24), down 56.8%. Weak margins on 162.6M revenue with only 23.9M profit (14.7% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

6 months โ†“ -56.24%

Novavax navigates difficult waters with a 6-month decline (9.14 โ†’ 4.00), down 56.2%. However, fundamentals remain robust: 626.3M revenue generating 518.6M profit (82.8% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note.

United States Market Monthly Gainers & Losers: January 2024

Top United States Stock Gainers (January 2024)

Stock Month Open Month Close Monthly Change Avg Daily Volume Month Volume
$49.24 $61.53 24.25% 441.2M 9.7B
$483.19 $564.11 15.86% 6.6M 145.9M
$144.28 $167.69 13.76% 88.9M 2.0B
$162.83 $183.66 12.30% 5.9M 129.9M
$580.41 $645.61 10.75% 2.8M 62.0M
$28.00 $52.96 86.28% 73.3M 1.6B
$29.36 $36.96 25.37% 8.3M 183.0M
$334.10 $397.57 18.71% 188.5K 4.1M
$46.08 $55.39 17.90% 621.0K 13.7M
$46.82 $56.20 17.84% 2.6M 58.0M
$45.63 $44.84 434.45% 112.8K 2.5M
$17.64 $37.95 116.86% 6.0M 131.4M
$8.15 $17.31 106.32% 78.0K 1.7M
$3.50 $6.33 85.09% 349.9K 7.7M
$11.20 $20.47 83.26% 263.6K 5.8M
$3.02 $9.35 198.72% 26.1K 573.1K
$15.20 $36.42 136.80% 1.8M 39.2M
$3.17 $5.87 81.73% 5.7M 124.8M
$0.13 $0.23 64.29% 0 0
$10.93 $17.83 62.98% 1.4M 30.3M

Biggest United States Stock Losers (January 2024)

Stock Month Open Month Close Monthly Change Avg Daily Volume Month Volume
$250.08 $187.29 -24.63% 106.5M 2.3B
$92.66 $87.24 -6.45% 9.3M 205.0M
$16.95 $16.09 -6.29% 40.0M 880.1M
$65.86 $62.91 -4.39% 5.1M 112.1M
$187.15 $184.40 -4.22% 54.0M 1.2B
$5.86 $2.87 -52.40% 6.1M 135.2M
$14.30 $8.33 -42.91% 13.1M 288.1M
$42.83 $25.86 -40.30% 7.8M 171.1M
$21.85 $15.31 -34.74% 30.4M 668.9M
$173.02 $128.20 -26.29% 14.4M 316.2M
$17.85 $4.89 -86.44% 21.8M 480.1M
$15.47 $15.32 -77.60% 197.3K 4.3M
$7.86 $3.92 -45.17% 5.6M 122.5M
$8.93 $5.62 -38.04% 62.9M 1.4B
$4.93 $3.10 -36.86% 29.8M 655.8M
$0.15 $0.03 -76.92% 35.6K 783.8K
$4.66 $1.68 -64.63% 31.6K 694.3K
$15.06 $7.47 -44.00% 6.9M 150.9M
$0.39 $0.30 -38.78% 0 0
$5.13 $3.21 -37.30% 323.3K 7.1M

Most Active United States Stocks During January 2024

Stock Month Open Month Close Monthly Change Avg Daily Volume Monthly Volume
$49.24 $61.53 24.25% 441.2M 9.7B
$250.08 $187.29 -24.63% 106.5M 2.3B
$26.64 $17.73 -24.52% 92.7M 2.0B
$144.28 $167.69 13.76% 88.9M 2.0B
$28.00 $52.96 86.28% 73.3M 1.6B
$8.93 $5.62 -38.04% 62.9M 1.4B
$9.71 $7.83 -21.31% 61.4M 1.4B
$187.15 $184.40 -4.22% 54.0M 1.2B
$4.44 $4.45 -1.11% 53.2M 1.2B
$12.04 $11.72 -3.86% 50.8M 1.1B
$4.17 $3.38 -19.71% 48.6M 1.1B
$49.20 $43.08 -14.27% 45.6M 1.0B
$28.88 $27.08 -5.94% 44.2M 972.7M
$151.54 $155.20 2.15% 43.3M 953.3M
$13.65 $14.23 3.57% 42.7M 938.7M
$4.93 $3.10 -36.86% 29.8M 655.8M
$1.51 $1.02 -32.45% 23.6M 518.1M
$5.49 $5.31 -4.32% 22.0M 483.2M
$2.93 $1.67 -30.42% 20.1M 442.4M
$6.09 $4.05 -33.82% 14.5M 318.0M

United States Sector Performance During January 2024

Healthcare

5.44%
1150 stocks
Top Performers by Market Cap:
Mega Cap: LLY +10.75%
Large Cap: COR +13.29%
Small Cap: NAMSW +198.72%

Financial Services

0.53%
925 stocks
Top Performers by Market Cap:
Mega Cap: BRK.B +7.59%
Large Cap: KNSL +18.71%
Mid Cap: FG +434.45%
Small Cap: AAMI +15.45%

Communication Services

-0.65%
248 stocks
Top Performers by Market Cap:
Mega Cap: NFLX +15.86%
Large Cap: SPOT +14.60%
Small Cap: TBLA +9.01%

Industrials

-1.30%
629 stocks
Top Performers by Market Cap:
Mega Cap: GE +3.75%
Large Cap: VRT +17.28%
Small Cap: ZIM +51.98%

Energy

-2.03%
198 stocks
Top Performers by Market Cap:
Mega Cap: XOM +2.83%
Large Cap: MPC +11.62%
Mid Cap: UEC +19.38%
Small Cap: TNK +25.18%

Technology

-2.65%
757 stocks
Top Performers by Market Cap:

Consumer Defensive

-3.25%
222 stocks
Top Performers by Market Cap:
Mega Cap: PG +7.23%
Large Cap: SYY +10.67%
Mid Cap: ELF +10.52%
Small Cap: UTI +12.78%

Real Estate

-5.54%
262 stocks
Top Performers by Market Cap:

Consumer Cyclical

-5.61%
565 stocks
Top Performers by Market Cap:

Utilities

-6.51%
95 stocks
Top Performers by Market Cap:
Large Cap: VST +6.52%
Mid Cap: TLNE +3.67%
Small Cap: ARIS +3.69%

Basic Materials

-8.99%
259 stocks
Top Performers by Market Cap:
Mega Cap: LIN -1.43%
Large Cap: NUE +7.41%
Mid Cap: TMC +19.09%
Small Cap: AMR +17.80%

Data is updated regularly. Monthly performance is calculated based on closing prices.